485-43-8 (（4S，4aS，7S，7aR）-4,7-二甲基六水力旋流器五[c]吡喃-3（1H）-酮,(4S,4aS,7S,7aR)-4,7-dimethylhexahydrocyclopenta[c]pyran-3(1H)-one)

(4S,4aS,7S,7aR)-4,7-dimethylhexahydrocyclopenta[c]pyran-3(1H)-one;(4aα,7aα)-Octahydro-4β,7α-dimethylcyclopenta[c]pyran-3-one;Cyclopenta[c]pyran-3(1H)-one, hexahydro-4,7-dimethyl-, (4.α.,4a.β.,7.β.,7a.β.)-(-)-;)-(-)-;,7β,7aβCyclopenta[c]pyran-3(1H)-one, hexahydro-4,7-dimethyl-;Cyclopenta[c]pyran-3(1H)-one, hexahydro-4,7-dimethyl-, (4α,4aβCyclopenta[c]pyran-3(1H)-one, hexahydro-4,7-dimethyl-, [4S-(4α,4aβIridomirmecina;Iridomyrmexin;Isoiridomyrmecin;9736R92EPU;SCHEMBL1649438;C09786;NSC-10974;IRIDOMYRMECIN [MI];IRIDOMYRMECIN, (+)-;CHEBI:5967;CYCLOPENTA(C)PYRAN-3(1H)-ONE, HEXAHYDRO-4,7-DIMETHYL-, (4S,4AS,7S,7AR)-;Q2016116;UNII-9736R92EPU;(4S,4aS,7S,7aR)-4,7-dimethyl-4,4a,5,6,7,7a-hexahydro-1H-cyclopenta[c]pyran-3-one;NSC 10974;CYCLOPENTA(C)PYRAN-3(1H)-ONE, HEXAHYDRO-4,7-DIMETHYL-, (4S-(4.ALPHA.,4A.BETA.,7.BETA.,7A.BETA.))-;Iridomyrmecin;.ALPHA.-(2-HYDROXYMETHYL-3-METHYLCYCLOPENTANE)PROPIONIC ACID .DELTA.-LACTONE;DTXSID40876125;Cyclopenta(c)pyran-3(1H)-one, hexahydro-4,7-dimethyl-, (4S-(4alpha,4abeta,7beta,7abeta))-;SureCN1649438;NS00010504;(+)-Iridomyrmecin;AC1L9CSW;485-43-8;

LYEFRAMOOLOUKA-RBXMUDONSA-N

1S/C10H16O2/c1-6-3-4-8-7(2)10(11)12-5-9(6)8/h6-9H,3-5H2,1-2H3/t6-,7-,8+,9+/m0/s1

O1C([C@@H](C)[C@H]2CC[C@H](C)[C@H]2C1)=O